Biomedical polymers have been extensively developed for promising applications in a lot of
biomedical fields, such as therapeutic medicine delivery, disease detection and diagnosis …

The use of small interfering RNAs (siRNAs) has been under investigation for the treatment of
several unmet medical needs, including acute lung injury/acute respiratory distress …

Bacterial infection is one of the greatest challenges to public health, requiring new
therapeutic methods. Herein, an innovative nanozyme‐armed phage (phage@ palladium …

RNA-based therapies have catalyzed a revolutionary transformation in the biomedical
landscape, offering unprecedented potential in disease prevention and treatment. However …

Sepsis is a disease caused by infection, which is characterized by a dysregulated immune
response in the host and affects more than 30 million people worldwide each year …

The lack of effective treatments for pulmonary diseases presents a significant global health
burden, primarily due to the challenges posed by the pulmonary barrier that hinders drug …

Interactions of lung macrophages and recruited neutrophils with the lung microenvironment
continuously aggravate the dysregulation of lung inflammation in the pathogenesis of acute …

Enzyme-regulated in situ self-assembly of peptides represents one versatile strategy in the
creation of theranostic agents, which, however, is limited by the strong dependence on …

Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a devastating
inflammatory lung disease with a high mortality rate. ALI/ARDS is induced by various …

Rationale: Development of novel nanomedicines to inhibit pro-inflammatory cytokine
expression and reactive oxygen species (ROS) generation for anti-inflammatory therapy of …